Grey matter reduction in the caudate nucleus in patients with persistent negative symptoms: An ALE meta-analysis

[1]  A. Aleman,et al.  Primary and persistent negative symptoms: Concepts, assessments and neurobiological bases , 2017, Schizophrenia Research.

[2]  K. Lim,et al.  A trend toward smaller optical angles and medial-ocular distance in schizophrenia spectrum, but not in bipolar and major depressive disorders. , 2016, PsyCh Journal.

[3]  Paolo Fusar-Poli,et al.  Dysfunctional insular connectivity during reward prediction in patients with first-episode psychosis. , 2016, Journal of psychiatry & neuroscience : JPN.

[4]  A. Cechnicki,et al.  The stability of negative syndrome, persistent negative syndrome and deficit syndrome in a twenty-year follow-up study of schizophrenia patients , 2016, Psychiatry Research.

[5]  E. Smeraldi,et al.  Adverse childhood experiences influence the detrimental effect of bipolar disorder and schizophrenia on cortico-limbic grey matter volumes. , 2016, Journal of affective disorders.

[6]  Cindy L. Hovington,et al.  Investigation of white matter abnormalities in first episode psychosis patients with persistent negative symptoms , 2015, Psychiatry Research: Neuroimaging.

[7]  D. Kelly,et al.  Rasagiline in the Treatment of the Persistent Negative Symptoms of Schizophrenia. , 2015, Schizophrenia bulletin.

[8]  A. Üçok,et al.  Persistent negative symptoms after first episode schizophrenia: A 2-year follow-up study , 2014, Schizophrenia Research.

[9]  Cindy L. Hovington,et al.  Cortical Thinning in Temporo-Parietal Junction (TPJ) in Non-Affective First-Episode of Psychosis Patients with Persistent Negative Symptoms , 2014, PloS one.

[10]  P. Chue,et al.  Addressing the unmet needs of patients with persistent negative symptoms of schizophrenia: emerging pharmacological treatment options , 2014, Neuropsychiatric disease and treatment.

[11]  D. Barch,et al.  The motivation and pleasure dimension of negative symptoms: Neural substrates and behavioral outputs , 2014, European Neuropsychopharmacology.

[12]  Matthias Kirschner,et al.  Poster #S165 APATHY BUT NOT DIMINISHED EXPRESSION IN SCHIZOPHRENIA IS ASSOCIATED WITH DISCOUNTING OF MONETARY REWARDS BY PHYSICAL EFFORT , 2014, Schizophrenia Research.

[13]  J. Waltz,et al.  A review of reward processing and motivational impairment in schizophrenia. , 2014, Schizophrenia bulletin.

[14]  Benjamin M. Robinson,et al.  Negative Symptoms of Schizophrenia Are Associated with Abnormal Effort-Cost Computations , 2013, Biological Psychiatry.

[15]  N. Andreasen,et al.  Progressive brain changes in schizophrenia related to antipsychotic treatment? A meta-analysis of longitudinal MRI studies , 2013, Neuroscience & Biobehavioral Reviews.

[16]  Cindy L. Hovington,et al.  Identifying persistent negative symptoms in first episode psychosis , 2012, BMC Psychiatry.

[17]  A. Lobo,et al.  Negative Symptoms and Executive Function in Schizophrenia: Does Their Relationship Change with Illness Duration? , 2012, Psychopathology.

[18]  G. Strauss,et al.  Negative symptoms and depression predict lower psychological well-being in individuals with schizophrenia. , 2012, Comprehensive psychiatry.

[19]  J. Foucher,et al.  Gray matter volume decreases in elderly patients with schizophrenia: a voxel-based morphometry study. , 2012, Schizophrenia bulletin.

[20]  M. Lepage,et al.  The Structural Neural Substrates of Persistent Negative Symptoms in First-Episode of Non-Affective Psychosis: A Voxel-Based Morphometry Study , 2012, Front. Psychiatry.

[21]  John W. Thatcher,et al.  Aberrant functional connectivity of cortico-basal ganglia circuits in major depression , 2012, Neuroscience Letters.

[22]  M. Lepage,et al.  Functional magnetic resonance imaging correlates of memory encoding in relation to achieving remission in first-episode schizophrenia. , 2012, The British journal of psychiatry : the journal of mental science.

[23]  Cindy L. Hovington,et al.  Neurocognition and neuroimaging of persistent negative symptoms of schizophrenia , 2012, Expert review of neurotherapeutics.

[24]  S. Haber.  Neuroanatomy of Reward: A View from the Ventral Striatum , 2011 .

[25]  M. Keshavan,et al.  Schizophrenia, “Just the Facts” 5. Treatment and prevention Past, present, and future , 2010, Schizophrenia Research.

[26]  D. Barch,et al.  Goal representations and motivational drive in schizophrenia: the role of prefrontal-striatal interactions. , 2010, Schizophrenia bulletin.

[27]  E. Bullmore,et al.  Meta-Analysis of Gray Matter Anomalies in Schizophrenia: Application of Anatomic Likelihood Estimation and Network Analysis , 2008, Biological Psychiatry.

[28]  H. Möller,et al.  Structural brain alterations at different stages of schizophrenia: A voxel-based morphometric study , 2008, Schizophrenia Research.

[29]  Annalena Venneri,et al.  Neuroanatomical correlates of neuropsychiatric symptoms in Alzheimer's disease. , 2008, Brain : a journal of neurology.

[30]  Monte S. Buchsbaum,et al.  Cortical gray and white matter volume in unmedicated schizotypal and schizophrenia patients , 2008, Schizophrenia Research.

[31]  Maximilian Reiser,et al.  Structural correlates of psychopathological symptom dimensions in schizophrenia: A voxel-based morphometric study , 2008, NeuroImage.

[32]  Michael J. Martinez,et al.  Bias between MNI and Talairach coordinates analyzed using the ICBM‐152 brain template , 2007, Human brain mapping.

[33]  R. Buchanan,et al.  Persistent negative symptoms in schizophrenia: an overview. , 2007, Schizophrenia bulletin.

[34]  M. Keshavan,et al.  Morphology of the orbitofrontal cortex in first-episode schizophrenia: Relationship with negative symptomatology , 2007, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[35]  Benedicto Crespo-Facorro,et al.  Caudate nucleus volume and its clinical and cognitive correlations in first episode schizophrenia , 2007, Schizophrenia Research.

[36]  Ferath Kherif,et al.  Multivariate voxel-based morphometry successfully differentiates schizophrenia patients from healthy controls , 2007, NeuroImage.

[37]  S. Stahl,et al.  Negative symptoms of schizophrenia: a problem that will not go away , 2007, Acta psychiatrica Scandinavica.

[38]  Geraldo F. Busatto,et al.  Insight and regional brain volumes in schizophrenia , 2007, European Archives of Psychiatry and Clinical Neuroscience.

[39]  B. Kirkpatrick,et al.  Subdomains within the negative symptoms of schizophrenia: commentary. , 2006, Schizophrenia bulletin.

[40]  A. Cohen,et al.  The structure of negative symptoms within schizophrenia: implications for assessment. , 2006, Schizophrenia bulletin.

[41]  Brian Kirkpatrick,et al.  The NIMH-MATRICS consensus statement on negative symptoms. , 2006, Schizophrenia bulletin.

[42]  M. Keshavan,et al.  Optimized voxel-based morphometry of gray matter volume in first-episode, antipsychotic-naïve schizophrenia , 2005, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[43]  Angela M. Uecker,et al.  ALE meta‐analysis: Controlling the false discovery rate and performing statistical contrasts , 2005, Human brain mapping.

[44]  P. McGuire,et al.  Structural brain differences in patients with schizophrenia and schizotypal disorder demonstrated by voxel–based morphometry , 2004, European Archives of Psychiatry and Clinical Neuroscience.

[45]  A. Malla,et al.  Can Patients at Risk for Persistent Negative Symptoms Be Identified During Their First Episode of Psychosis? , 2004, The Journal of nervous and mental disease.

[46]  Carles Falcón,et al.  Decreased cerebral activation during CPT performance structural and functional deficits in schizophrenic patients , 2004, NeuroImage.

[47]  H. Möller,et al.  Does considering duration of negative symptoms increase their specificity for schizophrenia? , 2003, Schizophrenia Research.

[48]  J B Poline,et al.  Cerebral gray and white matter reductions and clinical correlates in patients with early onset schizophrenia , 2001, Schizophrenia Research.

[49]  R Kikinis,et al.  Prefrontal gray matter volume reduction in first episode schizophrenia. , 2001, Cerebral cortex.

[50]  Y. Sudo,et al.  Ten year progressive ventricular enlargement in schizophrenia: An MRI morphometrical study , 2001, Psychiatry and clinical neurosciences.

[51]  T. Sigmundsson,et al.  Structural abnormalities in frontal, temporal, and limbic regions and interconnecting white matter tracts in schizophrenic patients with prominent negative symptoms. , 2001, The American journal of psychiatry.

[52]  P. McGorry,et al.  Enduring negative symptoms in first-episode psychosis: comparison of six methods using follow-up data , 1999, Schizophrenia Research.

[53]  Max A Viergever,et al.  Volumetric analysis of frontal lobe regions in schizophrenia: relation to cognitive function and symptomatology , 1999, Biological Psychiatry.

[54]  Alexander L. Miller,et al.  Predicting quality of life from symptomatology in schizophrenia at exacerbation and stabilization , 1999, Psychiatry Research.

[55]  Lynn E. DeLisi,et al.  Is schizophrenia a lifetime disorder of brain plasticity, growth and aging? , 1997, Schizophrenia Research.

[56]  R. A. Capleton,et al.  Cognitive Function in Schizophrenia: Association with Negative and Positive Symptoms , 1996, Psychological reports.

[57]  T. Crow,et al.  Clinical correlates of postmortem brain changes in schizophrenia: decreased brain weight and length correlate with indices of early impairment. , 1994, Journal of neurology, neurosurgery, and psychiatry.

[58]  W T Carpenter,et al.  Structural abnormalities in deficit and nondeficit schizophrenia. , 1993, The American journal of psychiatry.

[59]  A. Young,et al.  A Magnetic Resonance Imaging Study of Schizophrenia: Brain Structure and Clinical Symptoms , 1991, British Journal of Psychiatry.

[60]  N. Andreasen.  Neural Mechanisms of Negative Symptoms , 1989, British Journal of Psychiatry.

[61]  S. Stahl,et al.  Computed tomographic evidence for generalized sulcal and ventricular enlargement in schizophrenia. , 1988, Archives of general psychiatry.

[62]  D. Weinberger,et al.  Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia. IV. Further evidence for regional and behavioral specificity. , 1988, Archives of general psychiatry.

[63]  W. Carpenter,et al.  Deficit and nondeficit forms of schizophrenia: the concept. , 1988, The American journal of psychiatry.

[64]  J. Sweeney,et al.  Cognitive impairment in schizophrenia: Specific relations to ventricular size and negative symptomatology , 1988, Biological Psychiatry.

[65]  H. Meltzer,et al.  Lateral ventricular size, psychopathology, and medication response in the psychoses. , 1984, Biological psychiatry.

[66]  C. Golden,et al.  The BPRS is assessing symptom correlates of cerebral ventricular enlargement in acute and chronic schizophrenia , 1983, Psychiatry Research.